Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays
The grant opportunity is focused on addressing adherence to antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) for HIV treatment and prevention, a significant barrier despite advancements in medication formulations. There are anticipated 1 to 3 awards with a funding of $306,872 for Phase I (up to 1 year) and $2,045,816 for Phase II (up to 2 years). The aim is to develop methods f…
Source
Dates
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
National Institutes of Health
-
Fostering Collaboration Across Ryan White HIV/AIDS Programs (RWHAPs) to Engage People with HIV in Care
Health Resources and Services Administration
-
DoD funding for HIV prevention and treatment in foreign military health systems
Dept. of the Army -- USAMRAA
-
HIV Prevention and Alcohol (R34 Clinical Trials Optional)
National Institutes of Health ▸ National Institute on Alcohol Abuse and Alcoholism
-
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health ▸ National Institute on Alcohol Abuse and Alcoholism
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers